Skip to main content
COVID-19 In Vitro Diagnostic Devices and Test Methods Database

Scientific literature on COVID-19 Test Methods and Devices - detail

Comparison of abbott id now, diasorin simplexa, and CDC fda emergency use authorization methods for the detection of sars-cov-2 from nasopharyngeal and nasal swabs from individuals diagnosed with covid-19

Detection Principle
NucleicAcid-PCR based
Target
mixed
Testing Method Category
Mixed
Testing Method
ID Now (Abbott, USA), Simplexa (DiaSorin, Italy), WHO7 (CDC, modified)
Testing Method - Additional Info
letter to the editor
Reported Performance
Percent positive agreement: 94% (ID now), 96% (Simplexa)
Sample Size
96 samples
Assay Type
 
Peer-reviewed
no

The database contains available information from scientific literature that is being updated periodically. Please note that the provided information (as retrieved from analysed papers) is provided only for devices commercially available with CE-IVD mark. Acknowledgements